JournalsHub
.online
Find My Journal
TH

Thomas E. Hutson

Texas Tech University US

ORCID iD 0000-0002-4529-4212
412
Publications
50,781
Citations
75
H-Index
205
i10-Index
11.09
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

410 total

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma PDF

Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, Camillo Porta, Masatoshi Eto et al. - New England Journal of Medicine, 2021
Cited by 1,717 OpenAlex

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma PDF

David F. McDermott, Mahrukh Huseni, Michael B. Atkins, Robert J. Motzer, Brian I. Rini et al. - Nature Medicine, 2018
Cited by 1,238 OpenAlex

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma PDF

Toni K. Choueiri, Bernard Escudier, Thomas Powles, Paul N. Mainwaring, Brian I. Rini et al. - New England Journal of Medicine, 2015
Cited by 1,215 OpenAlex

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma PDF

Robert J. Motzer, Thomas E. Hutson, David Cella, James A. Reeves, Robert D. Hawkins et al. - New England Journal of Medicine, 2013
Cited by 1,905 OpenAlex

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib PDF

Jeffrey A. Sosman, Kevin B. Kim, Lynn M. Schuchter, René González, Anna C. Pavlick et al. - New England Journal of Medicine, 2012
Cited by 2,145 OpenAlex

Abiraterone and Increased Survival in Metastatic Prostate Cancer PDF

Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North et al. - New England Journal of Medicine, 2011
Cited by 4,377 OpenAlex

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Brian I. Rini, Bernard Escudier, Piotr Tomczak, А. Д. Каприн, Cezary Szczylik et al. - The Lancet, 2011
Cited by 1,840 OpenAlex

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski et al. - Journal of Clinical Oncology, 2009
Cited by 2,187 OpenAlex

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Robert J. Motzer, Bernard Escudier, Stéphane Oudard, Thomas E. Hutson, Camillo Porta et al. - The Lancet, 2008
Cited by 3,003 OpenAlex

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma PDF

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski et al. - New England Journal of Medicine, 2007
Cited by 5,739 OpenAlex

Research Topics

Renal cell carcinoma treatment (307) Cancer Genomics and Diagnostics (116) Renal and related cancers (97) Cancer Immunotherapy and Biomarkers (53) Economic and Financial Impacts of Cancer (49)

Affiliations

Privolzhsky Research Medical University
RU 2013 - 2013
University of Siena
IT 2011 - 2011
Texas Tech University
US 2025 - 2024
Texas A&M Health Science Center
US 2024 - 2012
National Health Service
GB 2012 - 2012

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now